PART I: An In-Depth Look at the Effects of the Genesis Case

March 21, 2024 11:45am

Stephen Forster
Partner
Morgan Lewis Bockius LLP

Constance Wilkinson
Board of Directors/Member of the Firm
Epstein Becker & Green, P.C.

  • Delving into what happened in the Genesis Case
  • Assessing the new patient definition
  • Understanding the effects of Genesis on the 340B program
  • Analyzing best practices that counsel and manufacturers need to know to navigate the implications of the Genesis case